Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...